El interés en corto de Moving iMage Technologies da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Moving iMage Technologies. Los datos de interés en corto se actualizan cada dos semanas.

Moving iMage Technologies (AMEX:MITQ) Bolsa, Informe de interés en corto

Moving iMage Technologies

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation, and digital technology, as well as software solutions for operations enhancement and theatre management.

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies Inc

News

Politics

General

Multiple Blasts Heard In Beirut, According To Reuters Witness, 'Massive Thick Clouds Of Smoke' Rising From City

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) with a Buy and maintains $10 price target.

Price Target

Reiteration

Analyst Ratings

LXRX

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $10 Price Target

Media

On CNBC: Tanger Outlet CEO Discusses Shopping Trends, Consumer Demand

WIIM

GDRX

PETS

Shares of pharmacy stocks are trading higher. Costco on its earnings call said pharmacy had the strongest sales percentage increase within ancillary businesses, with a double-digit script count growth, which could possibly be lifting the sector.

High-rolling investors have positioned themselves bullish on McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MCD often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for McDonald's. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 12% bearish. Among all the options we identified, there was one put, amounting to $107,640, and 7 calls, totaling $441,864.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $440.0 for McDonald's, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in McDonald's's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to McDonald's's substantial trades, within a strike price spectrum from $145.0 to $440.0 over the preceding 30 days.
<h3>McDonald's Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450251_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$163.9</td>
<td>$161.1</td>
<td>$162.7</td>
<td>$145.00</td>
<td>$113.8K</td>
<td>1</td>
<td>7</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$136.9</td>
<td>$132.5</td>
<td>$134.55</td>
<td>$440.00</td>
<td>$107.6K</td>
<td>0</td>
<td>8</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$2.9</td>
<td>$2.72</td>
<td>$2.9</td>
<td>$305.00</td>
<td>$66.7K</td>
<td>2.4K</td>
<td>355</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/04/24</td>
<td>$3.6</td>
<td>$3.45</td>
<td>$3.53</td>
<td>$305.00</td>
<td>$66.3K</td>
<td>2.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$3.1</td>
<td>$2.96</td>
<td>$3.1</td>
<td>$305.00</td>
<td>$62.0K</td>
<td>2.4K</td>
<td>642</td>
</tr>
</tbody>
</table>

<h3>About McDonald's</h3>
McDonald's is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
Following our analysis of the options activities associated with McDonald's, we pivot to a closer look at the company's own performance.
<h3>Current Position of McDonald's</h3>
<ul>
<li>With a volume of 533,349, the price of MCD is up 0.94% at $306.51. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 31 days.</li>
</ul>
<h3>What Analysts Are Saying About McDonald's</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $303.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs persists with their Neutral rating on McDonald's, maintaining a target price of $325. 
&#x2A; An analyst from TD Cowen has revised its rating downward to Hold, adjusting the price target to $280. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on McDonald's, maintaining a target price of $301. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for McDonald's, targeting a price of $320. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on McDonald's, which currently sits at a price target of $290. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for McDonald's, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

This Is What Whales Are Betting On McDonald's

Whales with a lot of money to spend have taken a noticeably bullish stance on Bitdeer Technologies.
Looking at options history for Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $112,000 and 6, calls, for a total amount of $567,404.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $10.0 for Bitdeer Technologies, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Bitdeer Technologies options trades today is 6177.5 with a total volume of 10,120.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Bitdeer Technologies's big money trades within a strike price range of $5.0 to $10.0 over the last 30 days.
<h3>Bitdeer Technologies Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450246_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.8</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$5.00</td>
<td>$285.9K</td>
<td>4.5K</td>
<td>819</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.45</td>
<td>$2.25</td>
<td>$2.27</td>
<td>$7.50</td>
<td>$107.1K</td>
<td>9.5K</td>
<td>740</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$0.4</td>
<td>$0.35</td>
<td>$0.35</td>
<td>$7.50</td>
<td>$81.8K</td>
<td>3.4K</td>
<td>2.3K</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.0</td>
<td>$2.3</td>
<td>$2.35</td>
<td>$10.00</td>
<td>$54.6K</td>
<td>7.2K</td>
<td>839</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.35</td>
<td>$2.05</td>
<td>$2.27</td>
<td>$7.50</td>
<td>$45.4K</td>
<td>9.5K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Bitdeer Technologies</h3>
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.
Following our analysis of the options activities associated with Bitdeer Technologies, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Bitdeer Technologies</h3>
<ul>
<li>Currently trading with a volume of 830,932, the BTDR's price is up by 4.06%, now at $8.32. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 45 days.</li>
</ul>
<h3>What The Experts Say On Bitdeer Technologies</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $13.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $13. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $14. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bitdeer Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

BTDR

Bitdeer Technologies's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SAVA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Cassava Sciences.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 46%, bearish.
Out of all of the special options we uncovered, 11 are puts, for a total amount of $1,182,634, and 4 are calls, for a total amount of $186,612.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $10.0 to $60.0 for Cassava Sciences during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cassava Sciences stands at 624.67, with a total volume reaching 6,170.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cassava Sciences, situated within the strike price corridor from $10.0 to $60.0, throughout the last 30 days.
<h3>Cassava Sciences Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450241_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.05</td>
<td>$25.00</td>
<td>$452.0K</td>
<td>153</td>
<td>5</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$7.4</td>
<td>$7.35</td>
<td>$7.35</td>
<td>$30.00</td>
<td>$166.8K</td>
<td>105</td>
<td>234</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.15</td>
<td>$2.8</td>
<td>$3.15</td>
<td>$20.00</td>
<td>$164.7K</td>
<td>902</td>
<td>273</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$25.00</td>
<td>$110.7K</td>
<td>153</td>
<td>1.1K</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.55</td>
<td>$8.5</td>
<td>$8.55</td>
<td>$60.00</td>
<td>$85.5K</td>
<td>1.4K</td>
<td>115</td>
</tr>
</tbody>
</table>

<h3>About Cassava Sciences</h3>
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Having examined the options trading patterns of Cassava Sciences, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Cassava Sciences</h3>
<ul>
<li>Trading volume stands at 3,473,313, with SAVA's price down by -13.12%, positioned at $27.69.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cassava Sciences with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

SAVA

Cassava Sciences Unusual Options Activity

On Friday, the FDA approved Regeneron Pharmaceuticals, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) and Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent&nbsp;(dupilumab) as an add-on maintenance treatment of inadequately controlled chronic obstructive pulmonary disease (COPD) and an <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g41067118/dupixent-dupilumab-approved-in-the-u-s-as-the-first-ever-biologic-medicine-for-patients-with-copd" rel="noreferrer noopener">eosinophilic phenotype</a>, generally known as &#8220;smoker&#8217;s lung.&#8221;
Dupixent is the first biologic medicine approved in the U.S. to treat these patients.&nbsp;&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40814475/sanofi-regeneron-drug-dupixent-shows-successful-treatment-of-patients-with-inflammatory-skin-dise" rel="noreferrer noopener">Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease</a>.
The FDA approval is based on data from two Phase 3 trials (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=7kKUkEN_j7dfFFaJgSlNFzKZoO4mFwp3ozmSi0rwdtS0dUmDMMLRg3ML03GEfgLzJP_Yg33hoRBP-3IabEFUjTEGB_rbTRFqm_JL_llzjsfHVLX2ednnpkFojo7lpUCTxdCo_2YiyMr0ctlswWAwXOheTav4f6f3NjyHRNKi9AkNKqyHtmSD_t9WycxSdyDJF-7MluPxoOJfAy9kkVjGMA==" rel="noreferrer noopener">BOREAS</a> and&nbsp;<a target="_blank" href="https://www.globenewswire.com/Tracker?data=6PGgHroz2kXLk3EuPbMe_MIJ-5vFWDjqk9axy8qZd2P7xQ3L3g2ASjHZ8xt1uzCTdZuMSDrpF3jIDhOGYYWxNY22Nyhv04bkd8VwfNHxSVov8kQjYXAerk1eaKGoDXJDxNmLd9JxB76ojM5ft65Yy_p10fVEAMfMBBDCl7C-sv2-eIX7C8dxYBsnfHK7AYcbsomWIUjlfALjFhRk2bqT3w==" rel="noreferrer noopener">NOTUS</a>) that evaluated the efficacy and safety of Dupixent compared to placebo in adults currently on maximal standard-of-care inhaled therapy (nearly all on triple therapy).
<ul>
<li>Patients who received Dupixent in BOREAS (n=468) and NOTUS (n=470) experienced the following outcomes, respectively, compared to placebo (BOREAS n=471; NOTUS n=465):</li>
<li>The primary endpoint is a 30% and 34% reduction in the annualized rate of moderate or severe COPD exacerbations over 52 weeks.</li>
<li>74mL and 68mL numerically greater improvements in post-bronchodilator FEV1 from baseline at week 12 compared to placebo, sustained at 52 weeks. Statistically significant improvements of similar magnitude were observed in pre-bronchodilator FEV1 from baseline at 12 and 52 weeks, a key secondary endpoint.</li>
<li>51% response in a health-related quality of life measure in both trials compared to 43% and 47% with placebo at 52 weeks.</li>
</ul>
About half of COPD patients continue to experience exacerbations despite being on triple inhaled therapy.
In the U.S., approximately 300,000 people live with inadequately controlled COPD and an eosinophilic phenotype.
Patients with an eosinophilic phenotype contribute to a ~30% increase in exacerbations and an increased risk of COPD-related re-hospitalizations within a year.
Today, China&#8217;s National Medical Products Administration also approved Dupixent&nbsp;(dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease characterized by <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g41063987/dupixent-dupilumab-approved-in-china-as-the-first-ever-biologic-medicine-for-patients-with-chronic" rel="noreferrer noopener">raised blood eosinophils</a>.
The approval is based on BOREAS and NOTUS Phase 3 trial results.
Price Action:&nbsp;At last check Friday, REGN stock was up 2.86% at $1,069.75, and SNY stock was up 1.49% at $57.85.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/41067826/federal-investigations-continue-for-psychiatric-hospital-chain-operator-acadia-healthcare-even-aft" target="_blank" rel="noreferrer noopener">Federal Investigations Continue For Psychiatric Hospital Chain Operator Acadia Healthcare Even After $20M Settlement Over False Claims Allegations</a>.</li>
</ul>

Biotech

Large Cap

Health Care

Movers

Trading Ideas

REGN

FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease

AGIO

Agios Pharmaceuticals shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and cut its price target on the stock from $60 to $56.

Senator Ron Wyden (D-OR) introduced the Cannabinoid Safety and Regulation Act (CSRA) on Wednesday, aiming to establish a federal framework for regulating hemp-derived cannabinoids like <a href="http://benzinga.com/topic/CBD">CBD</a> and <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained">Delta-8 THC</a>. The legislation seeks to protect public health by setting national standards on age restrictions, safety testing and labeling for <a href="http://benzinga.com/topic/hemp">hemp</a> products.
<h3 class="wp-block-heading">FDA To Oversee Hemp Product Safety And Access</h3>
Wyden&#8217;s CSRA proposes a national age limit of 21 for purchasing <a href="https://www.benzinga.com/markets/cannabis/24/07/39975361/hemp-derived-cannabinoids-vs-legal-cannabis-what-industry-members-are-saying-about-this-not-so-s">hemp-derived cannabinoid</a> products and mandates that all such products undergo safety and manufacturing testing to ensure clean processes. The bill empowers the Food and Drug Administration (FDA) to recall or ban cannabis products <a href="https://www.benzinga.com/markets/cannabis/24/07/39915334/a-nasty-high-experts-sound-alarm-over-soup-of-unknown-compounds-in-hemp-derived-thc-products">containing dangerous chemicals or additives</a>, ensuring truth in labeling.
&#8220;Just like the tobacco industry marketing cigarettes to young people, nobody should be slapping fun cartoons and glitzy candy wrapper packaging on cannabis products meant for adults,&#8221; Wyden <a href="https://www.wyden.senate.gov/news/press-releases/wyden-introduces-legislation-to-clean-up-hemp-market-keep-products-out-of-kids-hands">stated</a> in a press release. &#8220;A federal floor for regulation of hemp products is non-negotiable to ensure that consumers aren't put at risk by untested products of unknown origin. My legislation will ensure that adult consumers know what they're getting, and that hemp products are never sold or marketed to children.&#8221;
<h3 class="wp-block-heading">Synthetic Cannabinoids Would Face Federal Ban</h3>
The <a href="https://www.wyden.senate.gov/download/csra">legislation</a> allows states to impose their own regulations on hemp-derived products beyond the bill&#8217;s provisions. It also bans &#8220;artificially or synthetically derived cannabinoids and semi-synthetic cannabinoids,&#8221; <a href="https://www.wyden.senate.gov/imo/media/doc/cannabinoid_safety_and_regulation_act_section-by-sectionpdf.pdf">defined</a> as those produced through chemical synthesis, modification or conversion. The bill would prohibit adding cannabinoids to products containing alcohol, tobacco, nicotine or other substances that could interact with or enhance cannabinoid effects.
Synthetically derived cannabinoids like Delta-8 THC would also be federally banned. This means products containing Delta-8 THC synthesized from legal CBD would become illegal, significantly impacting their availability in state markets where they&#8217;re now being sold.
Further, the bill would establish a new FDA department, the Center for Cannabinoid Products, which would enforce bans on synthetically derived cannabinoids and regulate dosages in hemp products.
<h3 class="wp-block-heading">Industry Groups Back Wyden&#8217;s Hemp Bill</h3>
Co-sponsored by Senator Jeff Merkley (D-OR), the CSRA has garnered support from key industry groups, including the U.S. Hemp Roundtable and the National Cannabis Industry Association. 
&#8220;The hemp industry is united behind a simple, common-sense proposition: Hemp products should be robustly regulated, not the subject of a misguided prohibition,&#8221; said Jonathan Miller, general counsel at the U.S. Hemp Roundtable.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40833963/expert-calls-for-a-united-hemp-and-cannabis-front-industries-should-collaborate-and-push-for-fed">Expert Calls For A United Hemp And Cannabis Front, &#8216;Industries Should Collaborate&#8217; And Push For Federal Rules</a>
Clifford Starke, chairman and CEO of Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>), <a href="https://www.newsfilecorp.com/release/224598/Flora-Growth-Corp.-Applauds-Senator-Wyden-for-Introducing-the-Cannabinoid-Safety-and-Regulations-Act?k=cannabis">expressed</a> his support for the bill. &#8220;The introduction of the Cannabinoid Safety and Regulation Act represents a pivotal step forward for the cannabis and hemp industries. By establishing clear regulatory standards, this bill will not only protect public health and safety but also create a robust legal pathway for companies like Flora to deliver safe, high-quality cannabinoid products to adults. Importantly, it ensures that these products are rigorously tested, properly labeled, and age-restricted,&#8221; Starke <a href="https://www.newsfilecorp.com/release/224598/Flora-Growth-Corp.-Applauds-Senator-Wyden-for-Introducing-the-Cannabinoid-Safety-and-Regulations-Act?k=cannabis">stated</a> in a press release.
Wyden&#8217;s proposal emerges amid <a href="https://www.benzinga.com/markets/cannabis/24/07/39610764/intoxicating-hemp-products-face-regulatory-crackdown-across-multiple-states">growing state-level actions</a> to regulate or <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">ban synthetic hemp products</a>. The bill aims to address regulatory gaps that have <a href="https://www.benzinga.com/markets/cannabis/24/07/39783607/how-hemp-became-americas-loophole-for-legal-highs">existed since the 2018 Farm Bill</a>, which legalized hemp production but inadvertently opened the market to unregulated, psychoactive hemp-derived products like delta-9 THC <a href="https://www.benzinga.com/markets/cannabis/23/10/35305062/hemp-derived-thc-edibles-in-nostalgic-flavors-like-saltwater-taffy-freeze-pops-now-available-nat">edibles</a> and <a href="https://www.benzinga.com/markets/cannabis/24/09/41009554/tilray-brands-launches-hemp-derived-delta-9-thc-drinks-in-key-u-s-markets">beverages</a>.
<h3 class="wp-block-heading">Congressional Delays, Potential Backlash</h3>
While the CSRA seeks to balance consumer safety with industry growth, its passage remains uncertain due to legislative gridlock in Congress, <a href="https://mjbizdaily.com/hemp-bill-introduced-in-us-senate-would-ban-synthetic-thc/">notes</a> MJBizDaily. With challenges in advancing basic funding bills, more complex legislation like the CSRA may face delays.
Furthermore, the bill could spark controversy akin to recent events in Missouri and California, where regulatory actions on hemp-derived products <a href="https://www.benzinga.com/markets/cannabis/24/09/40945349/cannabis-companies-have-missouris-governor-beat-hemp-thc-products-sales-resume-as-stricter-contr">faced legal challenges and industry backlash</a>. Critics argue that such measures might inadvertently <a href="https://www.benzinga.com/markets/cannabis/24/09/40906131/this-is-life-or-death-families-of-disabled-children-panic-over-gov-newsoms-hemp-cbd-ban-and-eval">harm patients dependent on hemp-derived CBD treatments</a> and negatively impact the hemp industry, suggesting Wyden&#8217;s proposal may encounter similar opposition.
<h3 class="wp-block-heading">Impact On Hemp Investments</h3>
For investors, the introduction of the CSRA signals potential market shifts in the hemp and <a href="http://benzinga.com/cannabis">cannabis</a> industries. Increased regulation could impact companies <a href="https://www.benzinga.com/markets/cannabis/24/08/40418137/industrial-hemps-14b-projected-growth-an-investment-opportunity-too-good-to-miss">producing hemp-derived products</a>, affecting profitability and investment opportunities.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">Gov. Newsom&#8217;s Hemp Ban Goes Into Effect: Consequences For Industry, Investors, Patients</a></li>
</ul>
Image generated with AI tools.

Cannabis

Government

Regulations

FLGC

Synthetic Cannabinoids Could Be Federally Banned Under New Senate Bill To Regulate Hemp-Derived Products

TD Cowen analyst Oliver Chen maintains Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) with a Buy and lowers the price target from $26 to $25.

LEVI

TD Cowen Maintains Buy on Levi Strauss, Lowers Price Target to $25

In 2016, Warren Buffett, the legendary investor and CEO of Berkshire Hathaway, openly criticized Donald Trump during his presidential campaign. Buffett, a Democrat, was vocal about his support for Hillary Rodham Clinton and didn't hold back regarding Trump's controversial remarks and refusal to release his tax returns.&nbsp;
Don't Miss:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
</ul>
<a href="https://www.benzinga.com/general/24/02/37264271/warren-buffett-exposed-the-reason-for-trumps-failed-business-ventures-decades-before-the-fraud-case">Buffett challenged Trump to release his tax returns</a> and even disclosed his own, countering Trump's claims that Buffett took a massive deduction. &#8220;I have copies of all 72 of my returns and none uses a carry forward,&#8221; <a href="https://www.benzinga.com/general/23/12/36217808/trump-once-accused-warren-buffett-of-tax-evasion-despite-his-own-refusal-to-release-tax-returns-buff">Buffett said at the time</a>.&nbsp;
Trump made this assertion in reaction to criticism about his 1995 $916 million loss, which, according to reports, may have allowed him to avoid paying federal income taxes for several years.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Many predicted that Buffett&#8217;s investments might suffer if Trump won. But what transpired was very different. The stock market soared following Trump&#8217;s victory and Buffett&#8217;s company, Berkshire Hathaway, had one of its finest months in six years.&nbsp;
Despite Buffett's public disapproval of Trump's politics, the market&#8217;s response to the new administration's promises of tax cuts and deregulation benefited many of his holdings, especially those in financial services.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Berkshire Hathaway started as a struggling textile business but has since become a massive company that owns or invests in businesses across various industries, such as insurance, energy and everyday products. It holds big investments in companies like JPMorgan Chase, Goldman Sachs and Coca-Cola, among many others.&nbsp;
When Trump got elected, many on Wall Street thought his plans for higher interest rates and fewer regulations would benefit financial companies, which in turn helped boost Berkshire's profits.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Buffett&#8217;s refusal to let politics affect his investing choices is evidence of his investing philosophy. <a href="https://www.benzinga.com/general/education/24/08/40225783/warren-buffetts-approach-to-investing-in-election-years">Even though he backed Clinton</a>, he clarified that Berkshire would prosper regardless of the election outcome.
As he told shareholders then, &#8220;Berkshire would continue to do fine no matter which candidate was elected president.&#8221; Buffett's confidence was well-placed and his company prospered under Trump's presidency.
As we approach the 2024 election, people are curious<a href="https://www.benzinga.com/news/24/09/40956172/trump-vs-harris-will-warren-buffett-display-a-blue-or-red-dot-in-his-front-yard-neighbors-wait-to-se"> whether Buffett will support Kamala Harris</a>. People in his Omaha neighborhood are checking to see if his front yard will display a &#8220;blue-dot&#8221; sign for Democratic support. A neighbor started this grassroots movement to show Democratic support in a mostly Republican neighborhood. Although Buffett hasn&#8217;t disclosed his position, his daughter already has two blue-dot signs in her yard.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/charlie-munger-100k">Charlie Munger said if you want to be rich, &#8220;find a way to get your hands on $100,000&#8221; — here&#8217;s what he means.</a></li>
</ul>

Warren Buffett Spoke Out Against Trump In 2016. Ironically, He Was A Big Winner After Trump's Election Victory

RKLB

Rocket Lab shares are trading higher after Keybanc raised its price target on the stock from $8 to $11.

GameStop Shares Spike In Volume, Turn Positive

Nike (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) just announced that its current CEO has retired, and it&#39;s bringing in a long-time employee to take the helm. Elliott Hill will become Nike&#39;s CEO on Oct. 14. He hopes to be the new face the company needs to turn its fortunes around.
I&#39;ll detail Nike&#39;s history with lame-duck CEO John Donahoe and whether Hill is truly the spark needed to reignite the ailing consumer discretionary company.
<h2>How Donahoe Led Nike Astray</h2>
Since Donahoe took over as CEO of Nike in Jan. 2020, the company&#39;s performance has been disappointing, to say the least. Shares are down 14% over that time, greatly underperforming their sector. The Consumer Discretionary Select Sector SPDR Fund (ARCA: XLY) has managed to rise by 57%. Revenue has increased slowly over that period, rising a total of just 20% in just under four years.
The first few months of Donahoe&#39;s tenure may have tainted his overall strategy for the company. He entered the head role just two months before the beginning of COVID-19 lockdowns in the United States. In the following quarters, Nike&#39;s direct-to-consumer revenue stream saw massive growth. Donahoe believed this trend would continue and aimed to shift more of the company&#39;s revenue toward this business.
On the surface, it doesn&#39;t seem like a bad idea. Direct-to-consumer sales usually have higher margins, and companies cut out the middleman wholesalers, letting them keep more profit. However, it somewhat discounts the fact that going to the store and trying on a pair of shoes is a key element of the purchasing process for many.
But, more importantly, it also left brick-and-mortar stores with a dearth of inventory now that Nike was sending less supply. Notably, the percentage of Foot Locker&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fl#NYSE">FL</a>) inventory spending on Nike dropped from 75% in 2020 to 55% by the end of 2022. This opened the door for competitors to gain customer exposure, as Foot Locker needed inventory from different sources.
Previously unknown brands like On (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/onon#NYSE">ONON</a>) and Hoka were able to take advantage of this. In 2023, On received 63% of its revenue from wholesale sources and has seen its stock price rise over 50% in the past three years. Nike failed to realize how its overwhelming presence in retail stores kept new competitors from becoming well-known. The same was true for online wholesalers. Nike completely cut ties with e-commerce vendors like Zappos, causing them to need other inventory.
Another big criticism of the firm was Nike&#39;s push to sell through mobile apps. They wanted to innovate how they exposed customers to their products, but they weren&#39;t innovating the products themselves. They relied too much on very successful products and styles. They stopped pushing to create the next blockbuster shoe.
<h2>History Shows Hill Can Bring Nike Back to Its Roots and Stock Market Success</h2>
Elliott Hill began his career as an intern at Nike in 1988, just before the company had started cementing itself as the must-own shoe brand worldwide. Before its release, he watched the company&#39;s first &quot;Just Do It&quot; ad in a theater with other employees. Hill has a marketing background. He eventually worked his way up the company to oversee all commercial and marketing operations for Nike and its Jordan brand. He retired in 2020.
In the eyes of many, this is exactly what Nike needs right now. Nike has begun to move back toward relationships with wholesalers. Hill should help speed up this process. He likely worked directly with wholesale partners in his previous role. Also, after 30 years at the company, he saw all the successes and failures in product innovation and marketing that made Nike the top name in footwear.
The CEO before Donahoe was Matt Parker, a former sneaker designer. Under his reign, starting in 2006, Nike&#39;s stock provided a total return of 1,047% until Donahoe took over. That&#39;s over four times the total return of the S&amp;P 500 over that period. Donahoe, on the other hand, joined Nike after leading a cloud computing company.
<h2>Nike&#39;s Future: What to Watch For</h2>
Clearly, Nike performs better when its leader is steeped in product knowledge. Donahoe&#39;s hiring is a welcome return to that idea and has a great chance to change the market&#39;s tune on Nike. Still, it&#39;s important to hear the details of Elliot&#39;s plan before rushing back into the stock. Nike will likely provide more clarity around that at its Investor Day on Nov. 19.
The article &quot;<a href="https://www.marketbeat.com/originals/nikes-new-ceo-could-return-the-company-to-stock-market-glory/">Nike&#39;s New CEO Could Return the Company to Stock Market Glory</a>&quot; first appeared on MarketBeat.

Mid Cap

Events

ONON

Select Sector SPDR-Consumer Discretionary

Nike's New CEO Could Return the Company to Stock Market Glory

BlackBerry shares are trading lower. The company reported Q3 financial results.

In the Phase 3b/4 PSORIATYK SCALP trial Sotyktu was superior to placebo across all primary and secondary endpoints at Week 16, with patients reporting significantly greater improvement in symptoms
Safety profile in PSORIATYK SCALP was consistent with the established safety profile of Sotyktu
In the real-world RePhlect registry of patients, six months of Sotyktu treatment was consistent with the efficacy outcomes observed in the POETYK clinical studies for psoriasis
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com%2F&amp;esheet=54127020&amp;newsitemid=20240925005092&amp;lan=en-US&amp;anchor=Bristol+Myers+Squibb&amp;index=1&amp;md5=bea69efca57c5230176a4c6a25a3865c">Bristol Myers Squibb</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) today announced positive results from the Phase 3b/4 PSORIATYK SCALP trial evaluating Sotyktu (deucravacitinib) for the treatment of patients with moderate-to-severe scalp psoriasis, including those with less extensive overall psoriasis. The primary endpoint was met, with a statistically significant improvement in the scalp-specific Physician's Global Assessment (ss-PGA) response of 0 or 1 (clear/almost clear) at 16 weeks, with more than three times as many patients achieving ss-PGA 0/1 with Sotyktu treatment compared to those on placebo (48.5% versus 13.7%, respectively; p&lt;0.0001).
The new PSORIATYK SCALP efficacy and safety results (oral presentation FC04.07, abstract #5627), patient-reported outcomes (oral presentation FC06.06, abstract #5390) and 23 additional abstracts are being presented at the European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, Netherlands taking place September 25-28, 2024.

Bristol Myers Squibb Presents New Data From 2-Trials Demonstrating Sotyktu Efficacy In both Moderate-To-Severe Scalp Psoriasis And In A Real-World Setting; In The Phase 3b/4 PSORIATYK SCALP Sotyktu Was Superior To Placebo Across All Primary And Secondary Endpoints At Week 16, With Patients Reporting Significantly Greater Improvement In Symptoms

BTIG analyst Jake Fuller maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Buy and raises the price target from $150 to $175.

EXPE

BTIG Maintains Buy on Expedia Group, Raises Price Target to $175

Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) shares are trading higher by some 22% to $106.09 this week, fueled by a confluence of favorable <a href="https://www.benzinga.com/markets/asia/24/09/41011343/tech-stocks-rise-materials-sector-rallies-on-chinas-stimulus-nvidia-surges-whats-driving-markets-tue">macroeconomic developments</a> in China and optimism surrounding the company's future growth prospects. 
This week&#8217;s gain comes after the People's Bank of China (PBoC) announced aggressive monetary easing measures, which are expected to have wide-ranging positive effects on Chinese tech companies.
What Happened: The PBoC's decision to cut the reserve requirement ratio (RRR) for banks by 50 basis points, from 10.0% to 9.5%, is one of the most substantial easing measures seen in recent years. The move will inject approximately 1 trillion yuan ($140 billion) into the banking system, freeing up liquidity for lending and stimulating economic activity.
In addition, the central bank slashed both the seven-day repo rate and the 14-day reverse repo rate, further emphasizing its commitment to reviving China's economy, which has been under pressure from a property market slowdown and declining consumer confidence.
Read Also: <a href="https://www.benzinga.com/news/econ-s/24/09/41066122/feds-preferred-inflation-gauge-comes-in-below-expectations-for-august-easing-concerns-about-rising-p">Fed&#8217;s Preferred Inflation Gauge Comes In Below Expectations For August, Easing Concerns About Rising Prices</a>
This fresh wave of liquidity is expected to directly benefit companies like Baidu, which have significant exposure to sectors like AI, cloud computing, and autonomous driving that are heavily reliant on capital investment and government support. 
With banks now having more liquidity to lend, Baidu could see increased access to capital, facilitating the expansion of its AI capabilities, which remain a core pillar of the company's long-term growth strategy.
What Else: Beyond the immediate impact of the monetary easing, Baidu is also poised to benefit from the broader stimulus plans being discussed by Chinese authorities. Reports suggest that China may issue up to $284 billion in sovereign debt as part of a larger fiscal stimulus package. 
Such a package could bolster infrastructure spending, particularly in sectors like AI, autonomous driving, and smart cities, where Baidu has been heavily investing. As a leading player in AI, Baidu stands to gain from any policy measures aimed at boosting high-tech innovation and digital transformation in China.
Moreover, Baidu's strong position in China's digital economy has helped the stock rally in anticipation of stronger future earnings. The company's recent developments in AI—including its generative AI platform, Ernie Bot, which competes directly with OpenAI's ChatGPT—have placed Baidu at the cutting edge of global AI innovation. 
As China seeks to close the technological gap with the U.S. in this critical area, Baidu's leadership in AI could attract more government support and investor interest, making it a key beneficiary of the country's long-term tech ambitions.
Read Also: <a href="https://www.benzinga.com/general/biotech/24/09/41065699/sec-charges-cassava-sciences-over-manipulated-alzheimers-trial-data-company-and-former-execs-agre">SEC Charges Cassava Sciences Over Manipulated Alzheimer&#8217;s Trial Data, Company And Former Execs Agree To Pay Penalty</a>
Traders and investors can gain exposure to Baidu through KraneShares CSI China Internet ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NASDAQ">KWEB</a>) and iShares China Large-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>).
<h2 class="wp-block-heading">How To Buy BIDU Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Baidu&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BIDU has a 52-week high of $136.53 and a 52-week low of $79.68.

BIDU

KWEB

Why Baidu Stock Is Popping Off This Week

The rise of GameStop Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) was one of the biggest storylines of 2021 with investors<a href="https://www.benzinga.com/general/gaming/23/01/30412695/gamestop-short-squeeze-anniversary-a-look-back-at-david-vs-goliath-battle-and-whats-next"> profiting from a short squeeze.</a> 
Investors could have also profited from following an investment in the company by Chewy founder Ryan Cohen.
What Happened: Cohen, who disclosed his purchase of a 9% stake in GameStop in August 2020, was <a href="https://www.benzinga.com/news/management/24/05/38853075/ryan-cohens-wealth-soars-on-gamestop-stock-rally-how-much-is-video-game-retailer-ceo-worth">elected chairman of the board</a> in June 2021 and became the company&#8217;s CEO on Sept. 28, 2023.
In late 2020, Cohen increased his stake in GameStop to 13%. In total, he paid an average of $8.40 for his shares in 2020.
Based on a share price of $7.30 on Sept. 1, 2020, the day after Cohen's purchase was <a href="https://www.sec.gov/Archives/edgar/data/1326380/000119380520001571/0001193805-20-001571-index.htm">unveiled</a>, investors would have been able to buy 137 shares of GameStop with a $1,000 investment.
A 4-for-1 stock split by the video game retailer in July 2022 would have increased the stake to 548 GME shares.
Based on a price of $22.29 per share at the time of writing, the $1,000 investment would be worth $12,214.92 today. This represents a return of 1,121.5% over the last four years.
For comparison, the same $1,000 invested in the SPDR S&amp;P 500 Global ETF on Sept. 1, 2020, would be worth $1,628.48 today, for a return of +62.8%.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent092724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Cohen was one of the central characters in the GameStop storyline that played out in 2021 with retail investors taking on hedge funds in a short squeeze of epic proportions.
Investors bet on GameStop because they were confident in Cohen&#8217;s ability to address bankruptcy fears, a short squeeze, and the attention Keith Gill, aka Roaring Kitty, brought to the stock.
With news that short interest in GameStop was more than 100%, investors saw an opportunity to squeeze out the shorts and shares rose substantially,&nbsp;<a href="https://www.benzinga.com/news/21/01/19312927/gamestop-short-seller-melvin-gets-2-75b-funding-from-citadel-point72" target="_blank" rel="noreferrer noopener">causing millions of dollars in losses</a>&nbsp;for those betting against the stock.
GameStop shares hit a high of $483 in January 2021 and traded between $17.08 and $483 during the 2021 calendar year.
Investors who bought GameStop after Cohen disclosed his purchase and were able to time the trade perfectly to sell at all-time highs of $483 would have enjoyed turning the $1,000 investment into $66,171.
While shares of GameStop have dropped from their highs seen during the hedge fund battle, investors who bought in years ago remain profitable.
The return of Roaring Kitty <a href="https://www.benzinga.com/markets/equities/24/05/38787490/gamestop-shares-surge-as-roaring-kitty-resurfaces-after-3-year-silence">to social media</a> this year brought increased attention to GameStop once again and sent shares higher.
While Roaring Kitty has gone quiet about GameStop after a series of memes and videos and a brief return to livestreaming on YouTube, some investors remain confident in the long-term outlook of GameStop.
The video game retailer has been raising cash and is sitting on a balance that can be used for mergers and acquisitions, exploring new directions, or investing in stocks and cryptocurrency under Cohen&#8217;s guidance.
GME Price Action: GameStop stock trades at $22.29 versus a 52-week trading range of $9.95 to $64.83. GameStop stock is up 33.7% year-to-date in 2024. &nbsp;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40946963/bitcoin-worth-63-000-pulled-in-33-pack-of-trading-cards-at-gamestop-mind-boggling-story-go">Bitcoin Worth $63,000 Pulled In $33 Pack Of Trading Cards At GameStop: &#8216;Mind-Boggling&#8217; Story Goes Viral, Highlights Crypto Redemption Card</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Courtesy of Bill Jerome on Flickr and Shutterstock

Gaming

Education

If You Invested $1,000 In GameStop Stock When Ryan Cohen's Stake Was Disclosed, Here's How Much You'd Have Now

Moving iMage Technologies Inc (MITQ) Q3 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning!



Moving stocks are new deals and contracts, earnings reports, stock offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) stock is rocketing more than 821% on a deal to <a href="https://www.nasdaq.com/press-release/actelis-receives-new-orders-supply-three-military-bases-cyber-hardened-networking">supply technology to three military bases</a>.</li>



<li>MF International (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfi-stock-quote/">MFI</a>) shares are soaring over 139% with heavy trading roughly <a href="https://www.marketwatch.com/story/mf-international-shares-more-than-double-in-trading-debut-after-ipo-607bbac5">one month after its public debut</a>.</li>



<li>ENDRA Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) stock is surging more than 63% after falling yesterday on an <a href="https://www.investing.com/news/company-news/endra-life-sciences-sets-8-million-stock-offering-93CH-3470094">$8 million stock offering</a>.</li>



<li>WalkMe (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkme-stock-quote/">WKME</a>) shares are gaining over 43% on a <a href="https://seekingalpha.com/news/4112995-walkme-stock-leaps-after-15b-takeover-deal-with-sap?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">$1.5 billion takeover deal</a>.</li>



<li>Concord Medical Services (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/">CCM</a>) stock is rising more than 33% with strong early morning trading.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) shares are increasing over 25% after being <a href="https://www.nasdaq.com/press-release/moving-image-technologies-mit-awarded-multi-million-dollar-contract-state-art-alamo">granted a new contract</a>.</li>



<li>Jayud Global Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jyd-stock-quote/">JYD</a>) stock is heading more than 22% higher alongside heavy trading this morning.</li>



<li>U Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucar-stock-quote/">UCAR</a>) shares are climbing over 20% <a href="https://www.nasdaq.com/press-release/uotta-technology-be-adopted-portuguese-national-taxi-association-drive">on a deal</a> with the Portuguese National Taxi Association.</li>



<li>Stitch Fix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sfix-stock-quote/">SFIX</a>) stock is jumping more than 16% after <a href="https://finance.yahoo.com/news/stitch-fix-sfix-reports-q3-212003374.html">beating revenue estimates in fiscal Q3</a>.</li>



<li>Calidi Biotherapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/cldi-stock-quote/">CLDI</a>) shares are up over 14% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318374243&amp;type=PDF&amp;symbol=CLDI&amp;cdn=26f24d99b28a708fa7751a113b343d34&amp;companyName=Calidi+Biotherapeutics+Inc.&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-06-04">warrant exercise agreement</a>.</li>
</ol><h2>10 Top Losers</h2><ol></ol><ol><li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is retreating more than 26% <a href="https://investorplace.com/2024/06/why-is-microalgo-mlgo-stock-up-162-today/">following a rally yesterday</a>.</li>



<li>SilverSun Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/ssnt-stock-quote/">SSNT</a>) shares are diving close to 23% on <a href="https://ca.finance.yahoo.com/news/insider-sale-ceo-mark-meller-070316512.html">a CEO stock sale</a>.</li>



<li>Sobr Safe (NASDAQ:<a href="https://investorplace.com/stock-quotes/sobr-stock-quote/">SOBR</a>) stock is pulling back over 21% <a href="https://investorplace.com/2024/06/why-is-sobr-safe-sobr-stock-up-83-today/">after yesterday&rsquo;s rally</a>.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares are tumbling more than 18% without any clear news this morning.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) stock is taking an over 15% beating <a href="https://investorplace.com/2024/06/why-is-fresh2-group-fres-stock-up-31-today/">after climbing higher yesterday</a>.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) shares are sliding more than 14% despite a lack of news today.</li>



<li>Vast Renewables (NASDAQ:<a href="https://investorplace.com/stock-quotes/vste-stock-quote/">VSTE</a>) stock is dropping over 14% today.</li>



<li>ThredUp (NASDAQ:<a href="https://investorplace.com/stock-quotes/tdup-stock-quote/">TDUP</a>) shares are falling more than 12% on Wednesday.</li>



<li>ThermoGenesis (NASDAQ:<a href="https://investorplace.com/stock-quotes/thmo-stock-quote/">THMO</a>) stock is decreasing over 12% on an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318372198&amp;type=PDF&amp;symbol=THMO&amp;cdn=06c6f2748734640b337b89e0d63957b3&amp;companyName=ThermoGenesis+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-04">updated agreement with CBR Systems</a>.</li>



<li>MingZhu Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ygmz-stock-quote/">YGMZ</a>) shares close out our pre-market stock movers down more than 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is on the rise Wednesday after the cinema&nbsp;design and installation company received a new multi-million dollar contract.



According to <a href="https://finance.yahoo.com/news/moving-image-technologies-mit-awarded-110000789.html">a press release</a> from the company, it has signed on to build a new Alamo Drafthouse project for the company&rsquo;s new Georgetown. This is set to open for business this summer in Indianapolis, Ind.



Moving iMage Technologies notes that this new location will house a complete suite of its proprietary manufactured products. It will also feature 4K laser projection and full Q-sys AV distribution for clear visuals and audio.



Joe Delgado, executive vice president, sales and marketing at Moving iMage Technologies, said this about the contract.




&ldquo;The Georgetown location in Indianapolis is another example of our strong partnership with Alamo, one of North America&rsquo;s quickest-growing dine-in experience chains, and we&rsquo;re excited to be a part of this new project. This state-of-the-art cinema is the 44th Alamo site equipped by MiT, promising an unparalleled cinematic experience for local audiences.&rdquo;




<h2>MITQ Stock Movement on Wednesday</h2>



News of this deal brings with it heavy trading of MITQ shares as investors buy the stock. This has more than 52 million shares on the move as of this writing. That&rsquo;s well above its daily average trading volume of about 73,000 shares.



MITQ stock is up 60.2% as of Wednesday morning.



There are plenty of other stock market stories for readers to sink their teeth into today!



Fortunately, we have all of that news ready to go with our market coverage on Wednesday! A few examples include what&rsquo;s going on with shares of Archer Aviation&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/achr-stock-quote/">ACHR</a>), GameStop&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) and Nike&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nke-stock-quote/">NKE</a>). All of this news is available below!



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>



<li><a href="https://investorplace.com/2024/06/heres-how-roaring-kitty-could-become-gamestop-gme-stock-fourth-largest-shareholder/">Here&rsquo;s How Roaring Kitty Could Become GameStop (GME) Stock&rsquo;s Fourth-Largest Shareholder</a></li>



<li><a href="https://investorplace.com/2024/06/nike-layoffs-2024-what-to-know-about-the-latest-european-job-cuts/">Nike Layoffs 2024: What to Know About the Latest European Job Cuts</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Deere (NYSE:<a href="https://investorplace.com/stock-quotes/de-stock-quote/">DE</a>) layoffs are a hot topic on Wednesday after the tractor and farm equipment company announced <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318375045&amp;type=PDF&amp;symbol=DE&amp;cdn=936da5c1741f9f6e860166cd73ae50f2&amp;companyName=Deere+%26+Company&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-05">job cuts coming in 2024</a>.



Deere let its employees know about the layoffs and then announced them to the public via a filing with the Securities and Exchange Commission (SEC). In that filing, the company notes that it is reducing jobs in its production and salaried workforce.



Deere is enacting these layoffs to help it meet strategic priorities while also reducing overlap. It will also help cut down on redundant roles and responsibilities at the company.



Deere also notes that it is expecting these layoffs to start later this year. The company says the salaried portion of the jobs cuts will take place in the third quarter of 2024. It also says these workforce reductions don&rsquo;t change its previous guidance from May 16.



<h2>Deere Layoffs Extend Trend</h2>



There have been plenty of layoffs taking place at more than just Deere recently. Many companies are working to cut operating costs as they deal with a tough economy. That includes high inflation and interest rates.



DE stock is down slightly as of Wednesday morning. That comes without much trading as only 359,000 units have changed hands. Its daily average trading volume is about 1.4 million shares.



Investors will want to keep reading for more of the most recent stock market stories today!



We have all of the hottest stock market news traders need to know about on Wednesday! That includes everything happening with shares of Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock, Archer Aviation&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/achr-stock-quote/">ACHR</a>) stock and GameStop&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) stock today. You can read up on all of these matters at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>



<li><a href="https://investorplace.com/2024/06/heres-how-roaring-kitty-could-become-gamestop-gme-stock-fourth-largest-shareholder/">Here&rsquo;s How Roaring Kitty Could Become GameStop (GME) Stock&rsquo;s Fourth-Largest Shareholder</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/deere-layoffs-2024-what-to-know-about-the-latest-job-cuts/">Deere Layoffs 2024: What to Know About the Latest Job Cuts</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Deere Layoffs 2024: What to Know About the Latest Job Cuts

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Hanesbrands&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/hbi-stock-quote/">HBI</a>) stock is getting a boost on Wednesday after the innerwear apparel company announced it will <a href="https://finance.yahoo.com/news/hanesbrands-signs-agreement-sell-global-114500683.html">sell the Champion brand</a>.



Hanesbrands&nbsp;has agreed to sell the Champion brand to Authentic Brands Group&nbsp;for $1.2 billion. The deal could increase to $1.5 billion if a contingent cash consideration of up to $300 million is fulfilled. This requires the brand to reach performance goals after the sale.



Hanesbrands&nbsp;notes that it will receive net proceeds of $900 million from this deal. The company says that it intends to use all of the funds gained from this sale to pay down its debts.



<h2>What This Means for HBI Stock</h2>



Hanesbrands&nbsp;says that the sale of Champion will take place in the second half of 2024. The company also intends to list it as discontinued operations in its filings starting in Q2 of the year. It will also update its guidance to adjust for the sale when it releases its Q2 results.



Steve Bratspies, CEO of Hanesbrands, said this about the sale.




&lsquo;Over the past three years, we have taken necessary actions to enhance the Company&rsquo;s operations and financial performance &ndash; returning to historical gross margins, reducing our cost structure, lowering our debt levels, and generating consistent cash flow. The successful completion of this transaction further simplifies our business, deleverages our balance sheet and enhances the Company&rsquo;s operations and financial performance.&rdquo;




HBI stock is up 5.1% as of Wednesday morning.



There are plenty of other stock market stories ready to go below!



We have all of the hottest stock market news traders need to know about on Wednesday! Among this is what&rsquo;s going on with Deere&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/de-stock-quote/">DE</a>) layoffs, why Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is up today and more. All of this info is available at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/deere-layoffs-2024-what-to-know-about-the-latest-job-cuts/">Deere Layoffs 2024: What to Know About the Latest Job Cuts</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/hbi-stock-hanesbrands-jumps-on-deal-to-sell-champion-brand-for-1-2-billion/">HBI Stock: Hanesbrands Jumps on Deal to Sell Champion Brand for $1.2 Billion</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HBI Stock: Hanesbrands Jumps on Deal to Sell Champion Brand for $1.2 Billion

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!



Moving stocks this morning is heavy trading, drug approval, a clinical hold and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is rocketing more than 118% alongside heavy pre-market trading.</li>



<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are soaring over 54% with strong early morning trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock is surging more than 22% without any clear news on Friday morning.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) shares are increasing over 22% despite a lack of news today.</li>



<li>Geron (NASDAQ:<a href="https://investorplace.com/stock-quotes/gern-stock-quote/">GERN</a>) stock is gaining more than 21% after getting <a href="https://finance.yahoo.com/news/fda-approves-geron-rytelo-mds-082526023.html">approval for its blood disorder drug</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are rising over 16% with strong early morning trading today.</li>



<li>Braze (NASDAQ:<a href="https://investorplace.com/stock-quotes/brze-stock-quote/">BRZE</a>) stock is heading more than 15% higher alongside its <a href="https://www.nasdaq.com/press-release/braze-reports-fiscal-first-quarter-2025-results-2024-06-06">latest earnings release</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are jumping over 12% with <a href="https://investorplace.com/2024/06/short-interest-in-faraday-future-ffie-stock-falls-below-3/">falling short interest</a>.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is getting a more than 12% boost are slipping yesterday.</li>



<li>ReTo Eco-Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/reto-stock-quote/">RETO</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Biomea Fusion (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmea-stock-quote/">BMEA</a>) stock is plummeting more than 60% after <a href="https://finance.yahoo.com/news/biomea-fusion-announces-bmf-219-200500839.html">announcing a clinical hold</a>.</li>



<li>Virax Biolabs (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrax-stock-quote/">VRAX</a>) shares are diving over 20% <a href="https://investorplace.com/2024/06/why-is-virax-biolabs-vrax-stock-up-115-today/">after rallying yesterday</a>.</li>



<li>Xylo Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/xylo-stock-quote/">XYLO</a>) stock is tumbling more than 19% <a href="https://www.nasdaq.com/press-release/xylo-gix-internet-signed-mou-investment-and-merger-ai-robotics-company-2024-06-06">on merger plans</a> for a company it holds a significant stake in.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) shares are taking an over 18% beating as it continues recent negative movement.</li>



<li>Jayud Global Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jyd-stock-quote/">JYD</a>) stock is sliding more than 18% this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) shares are falling over 15% on Friday.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) stock is dropping close to 14% today.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) shares are decreasing more than 13% on Friday morning.</li>



<li>CalAmp (NASDAQ:<a href="https://investorplace.com/stock-quotes/camp-stock-quote/">CAMP</a>) stock is declining over 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318378043&amp;type=PDF&amp;symbol=CAMP&amp;cdn=15857b89629f6fd8bb5ccdef99a68bb0&amp;companyName=CalAmp+Corp.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-06">on insider selling</a>.</li>



<li>Sacks Parente Golf (NASDAQ:<a href="https://investorplace.com/stock-quotes/spgc-stock-quote/">SPGC</a>) shares close out our pre-market stock movers down more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318375423&amp;type=PDF&amp;symbol=SPGC&amp;cdn=84160401cba989fd4733d9364b53757e&amp;companyName=Sacks+Parente+Golf+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-05">on delisting woes</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-7th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!



Moving stocks this morning are acquisitions, earnings reports, pricings of public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Foxo Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/foxo-stock-quote/">FOXO</a>) stock is rocketing more than 47% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318393600&amp;type=PDF&amp;symbol=FOXO&amp;cdn=2bd1b7f22a5eca4e128f551cdaab6e19&amp;companyName=FOXO+Technologies+Inc.+Class+A&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-13">on two acquisition deals</a>.</li>



<li>Chijet Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/">CJET</a>) shares are soaring over 32% alongside heavy premarket trading.</li>



<li>Vaxart (NASDAQ:<a href="https://investorplace.com/stock-quotes/vxrt-stock-quote/">VXRT</a>) stock is surging more than 24% after getting <a href="https://finance.yahoo.com/news/vaxart-receives-barda-funded-project-201500150.html">a $453 million award</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are gaining over 21% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318391892&amp;type=PDF&amp;symbol=KITT&amp;cdn=cd810aaaa8036c7dff56dd4a6d040684&amp;companyName=Nauticus+Robotics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-13">following an offering update</a>.</li>



<li>CuriosityStream (NASDAQ:<a href="https://investorplace.com/stock-quotes/curi-stock-quote/">CURI</a>) stock is increasing more than 20% without any clear news this morning.</li>



<li>La Rosa (NASDAQ:<a href="https://investorplace.com/stock-quotes/lrhc-stock-quote/">LRHC</a>) shares are climbing over 15% with strong early morning trading.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is heading more than 15% higher despite a lack of news this morning.</li>



<li>Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) shares are rising over 14% <a href="https://www.cnbc.com/2024/06/13/adobe-adbe-q2-earnings-report-2024.html">on earnings results</a>.</li>



<li>PainReform (NASDAQ:<a href="https://investorplace.com/stock-quotes/prfx-stock-quote/">PRFX</a>) stock is jumping more than 14% without any apparent news this morning.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) shares are up over 13% on <a href="https://www.nasdaq.com/press-release/molecular-partners-presents-positive-preclinical-data-first-switch-darpin-candidate-0">positive preclinical data</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) stock is diving more than 27% following a <a href="https://www.nasdaq.com/press-release/nexalin-technology-announces-regulatory-approval-sell-nexalins-gen-2-15-ma">major rally yesterday</a>.</li>



<li>Gain Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ganx-stock-quote/">GANX</a>) shares are tumbling over 27% after <a href="https://www.nasdaq.com/press-release/gain-therapeutics-announces-pricing-110-million-public-offering-2024-06-13">pricing a public offering</a>.</li>



<li>Rezolute (NASDAQ:<a href="https://investorplace.com/stock-quotes/rzlt-stock-quote/">RZLT</a>) stock is taking a more than 18% beating with the <a href="https://www.nasdaq.com/press-release/rezolute-announces-pricing-public-offering-60-million-common-stock-and-pre-funded">pricing of a public offering</a>.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) shares are sliding over 17% <a href="https://www.globenewswire.com/news-release/2024/06/13/2898721/0/en/QXO-Announces-3-5-Billion-Private-Placement.html">on a private placement</a>.</li>



<li>Ostin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ost-stock-quote/">OST</a>) stock is dropping 17% without any obvious news to report.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) shares are falling more than 16% this morning.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is decreasing over 14% <a href="https://www.investing.com/news/company-news/spectaire-holdings-faces-nasdaq-delisting-over-market-value-93CH-3484080">as it risks delisting</a>.</li>



<li>Neo-Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/nci-stock-quote/">NCI</a>) shares are slipping more than 13% <a href="https://investorplace.com/2024/06/why-is-neo-concept-nci-stock-up-61-today/">after a rally yesterday</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is retreating over 12% <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">following a recent rally</a>.</li>



<li>Enservco (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ensv-stock-quote/">ENSV</a>) shares close out our pre-market stock movers down more than 12% as it <a href="https://www.nasdaq.com/press-release/enservco-corporation-provides-further-update-plan-regain-compliance-nyse-american">tries to avoid delisting</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Moving iMage Technologies gets new project in New Mexico

Earnings week ahead: Micron, Costco, BlackBerry, Accenture and more

Moving iMage Technologies reports Q4 results

ACHR

ADBE

ASNS

BBLG

BMEA

BRZE

BTOC

CAMP

CJET

CLDI

CNXC

COST

CRKN

CTAS

CURI

ENSV

FFIE

FOXO

FRES

GANX

GDHG

GERN

GOVX

KAVL

KITT

KRKR

LILM

LRHC

MITQ

MLGO

MOLN

NAPA

NDRA

PRFX

PRGS

PRST

RCAT

RETO

RZLT

SCHL

SFIX

SOBR

SPEC

SPGC

SSNT

TDUP

THMO

TPHS

UCAR

UXIN

VERO

VIRX

VRAX

VSTE

VXRT

WKME

XYLO

YGMZ

ZAPP

Press Releases

Moving iMage Technologies (MiT) Announces Stock Repurchase Program and 10b5-1 Stock Trading Plan

Moving iMage Technologies Third Quarter Fiscal 2024 Results Conference Call and Webcast

Moving iMage Technologies Announces Third Quarter Fiscal 2024 Results

Moving iMage Technologies (MiT) Awarded Multi-Million Dollar Contract for State-of-the-Art Alamo Drafthouse Cinema in Indianapolis

Moving Image Technologies to Upgrade Alamo Drafthouse's Recently Acquired Richardson, Texas Location

Moving iMage Technologies to Upgrade Alamo Drafthouse's Recently Acquired Las Colinas, Texas Location

Moving iMage Technologies to Upgrade Premium Large Format Auditoriums With Immersive Sound Systems for Two Customers

Moving iMage Technologies Awarded Project for State-of-the-Art Flix Brewhouse Cinema in Albuquerque

Moving iMage Technologies Fourth Quarter and Full Year Fiscal 2024 Results Conference Call and Webcast

Moving iMage Technologies Announces Fourth Quarter and Full Year Fiscal 2024 Results

BloomZ

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Cineverse

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares, each representing one Ordinary Share

Kuke Music Hldg

Lytus Technologies Holdings PTV. Ltd. - Common Shares

Lytus Technologies Hldgs

MultiMetaVerse Holdings Limited - Class A Ordinary Share

MultiMetaVerse Holdings

Reading International Inc - Class A Non-voting Common Stock

Reading Intl

Scienjoy Holding Corporation - Class A Ordinary Shares

Scienjoy Holding

Sound Group Inc. - American Depositary Shares

Sound Group

Kartoon Studios

Comments

Moving iMage Technologies

Interés en corto

Moving iMage Technologies (AMEX:MITQ) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL